Heart Failure Statistics 2024 Update: A Report From the Korean Society of Heart Failure

Chan Joo Lee(Yonsei University), Hokyou Lee(Yonsei University), Minjae Yoon(Seoul National University Bundang Hospital), Kyeong‐Hyeon Chun(National Health Insurance Service Ilsan Hospital), Min Gyu Kong(Soonchunhyang University), Mi‐Hyang Jung(The Catholic University of Korea Seoul St. Mary's Hospital), In‐Cheol Kim(Keimyung University), Jae Yeong Cho(Chonnam National University Hospital), Jeehoon Kang(Seoul National University Hospital), Jin Joo Park(Seoul National University Bundang Hospital), Hyeon Chang Kim(Yonsei University), Dong‐Ju Choi(Seoul National University Bundang Hospital), Jungkuk Lee(Hanmi Pharmaceutical (South Korea)), Seok‐Min Kang(Yonsei University)
International Journal of Heart Failure
January 1, 2024
Cited by 60Open Access
Full Text

Abstract

Background and Objectives: The number of people with heart failure (HF) is increasing worldwide, and the social burden is increasing as HF has high mortality and morbidity. We aimed to provide updated trends on the epidemiology of HF in Korea to shape future social measures against HF. Methods: We used the National Health Information Database of the National Health Insurance Service to determine the prevalence, incidence, hospitalization rate, mortality rate, comorbidities, in-hospital mortality, and healthcare cost of patients with HF from 2002 to 2020 in Korea. Results: The prevalence of HF in the total Korean population rose from 0.77% in 2002 to 2.58% (1,326,886 people) in 2020. Although the age-standardized incidence of HF decreased over the past 18 years, the age-standardized prevalence increased. In 2020, the hospitalization rate for any cause in patients with HF was 1,166 per 100,000 persons, with a steady increase from 2002. In 2002, the HF mortality was 3.0 per 100,000 persons, which rose to 15.6 per 100,000 persons in 2020. While hospitalization rates and in-hospital mortality for patients with HF increased, the mortality rate for patients with HF did not (5.8% in 2020), and the one-year survival rate from the first diagnosis of HF improved. The total healthcare costs for patients with HF were approximately $2.4 billion in 2020, a 16-fold increase over the $0.15 billion in 2002. Conclusions: The study's results underscore the growing socioeconomic burden of HF in Korea, driven by an aging population and increasing HF prevalence.


Related Papers

No related papers found

Powered by citation graph analysis